Navigation Links
Genomma Lab Announces Its 2010 Earnings Guidance
Date:12/11/2009

MEXICO CITY, Dec. 11 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announces today its 2010 earnings guidance.

Genomma Lab expects net sales growth in the range of 42% to 45% for the full year of 2010, excluding possible acquisitions, and an EBITDA margin between 25.0% and 26.0%, from 2009 year-end results which we expect to be above our last issued guidance.

The Company's estimates are based on organic growth in base line products, the full year effect in sales of products launched or acquired during 2009, growth in international operations as well as product line extensions and new brands in existing and new categories.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Latin America. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has a sound business model through a unique combination of a new product development process, consumer oriented marketing, a broad retail distribution network and a low-cost, highly flexible supply chain operating model.

    Contact: Oscar Villalobos
    Tel:  +52 (55) 5081- 0000 ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3695
    E-mail: genomma@i-advize.com

SOURCE Genomma Lab Internacional, S.A.B. de C.V.


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Strategic Alliance Between Televisa and Genomma Lab
2. Genomma Lab Internacional Revises 2009 Earnings Guidance
3. Strategic Alliance Between Televisa and Genomma Lab
4. Genomma Lab International Announces Second Quarter 2009 Results
5. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. Announces Second Quarter 2009 Results Conference Call
6. Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
7. Genomma Lab Internacional Announces First Quarter 2009 Results
8. Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
9. Genomma Lab Internacional Announces Fourth Quarter and Full Year 2008 Results
10. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
11. Genomma Lab Announces Updated Fourth Quarter 2008 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, ... ... released a video, “Beachside Nursing Center,” to announce its position as one ... ratings. Beachside's administrator and staff members support the CMS rating system, which ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax ... New Tool That Increases Training Capability , World renown body weight trainer, ... ( http://www.Zejax.com ), that dramatically increases a person’s training capability. , The American ...
(Date:7/30/2015)... ... 2015 , ... Boston Web Marketing is proud ... Partners is the platform for search marketing agencies to communicate with the Google ... to run successful search marketing campaigns. Google Partners also affords businesses the opportunity ...
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile surgeon, Dr. Alex ... and surgery, as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a ... with many patients from around the world. , “Like treatment of any other disease ...
(Date:7/30/2015)... ... , ... InventHelp, a leading inventor service company, announces that one ... it easy to apply lotion or medication to a hard-to-reach area. This invention is ... or medication to the back, and provides thorough coverage. The product would prevent the ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... ... ... ... ...
... When stroke strikes, choking off blood supply to the brain, ... a stroke is left untreated, making it a race to ... Forty-five percent of Americans 135 million people -- are ... facilities that are best equipped to care for them if ...
... Mission ... bolstering the fund’s ability to invest in promising bioscience companies emerging from the University ... ... partner to its first venture fund, bolstering the fund’s ability to invest in promising ...
... , ... Agency, FlexRN, Unveils New Corporate Branding & Website , ... Stafford, VA (PRWeb) February 23, 2010 -- FlexRN, ... of its new corporate branding and the launch of its new website at ...
... children, report says , WEDNESDAY, Feb. 24 (HealthDay News) ... uninsured children with asthma by 75 percent by enrolling ... programs and expanding eligibility, a new report suggests. , ... for kids with asthma costs an average of 50 ...
... ... ... ... ...
Cached Medicine News:Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 2Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 3Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 4Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 5Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 6Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 7Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 8Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 9Health News:Half of Americans live more than an hour away from lifesaving stroke care 2Health News:Half of Americans live more than an hour away from lifesaving stroke care 3Health News:QB3 Adds Zcube As Limited Partner In Mission Bay Capital Fund 2Health News:QB3 Adds Zcube As Limited Partner In Mission Bay Capital Fund 3Health News:QB3 Adds Zcube As Limited Partner In Mission Bay Capital Fund 4Health News:Nurse Staffing Agency, FlexRN, Unveils New Corporate Branding & Website 2Health News:Existing Health Programs Could Help More Kids With Asthma 2Health News:Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel 2Health News:Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel 3Health News:Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel 4
(Date:7/30/2015)... 30, 2015 Takeda Pharmaceutical Company Limited ... fulfill the post-marketing commitment and submissions of data ... Multi-Database Bladder Cancer Risk Characterization Study , a ... conducted in four European countries, for pioglitazone containing ... 10 years of follow-up. Findings demonstrate that there ...
(Date:7/30/2015)... SAN FRANCISCO , July 30, 2015 ... devices market is expected to reach USD 23.01 ... Grand View Research, Inc. Growing base of geriatric population, ... and infections, and rising level of awareness among target ... impact rendering drivers over the forecast period. According to ...
(Date:7/30/2015)... What can be expected from ... going to grow at the fastest rates? Visiongain ... 2025, assessing data, trends, opportunities and prospects there. ... charts, and graphs. Discover the most lucrative areas in ... study lets you assess forecasted sales at overall world ...
Breaking Medicine Technology:Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... response to outbreaks of swine flu across North ... service, has issued professionally-written influenza notification scripts for ... protect the millions of families currently receiving One ... announced a NO-Charge, proactive emergency calling plan for ...
... two prospective, double-blind placebo controlled multi-center studies in patients ... and safety data in patients with focal dystonia and ... American Academy of Neurology,s (AAN) 61st annual meeting in ... which plans to file a Biologic License Application (BLA) ...
Cached Medicine Technology:One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak 2One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak 3Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 2Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 3Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 4Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 5
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
Medicine Products: